Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk


Tahan V., Canbakan B., Balci H., Dane F., Akin H., Can G., ...More

HEPATO-GASTROENTEROLOGY, vol.55, no.85, pp.1433-1438, 2008 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 55 Issue: 85
  • Publication Date: 2008
  • Title of Journal : HEPATO-GASTROENTEROLOGY
  • Page Numbers: pp.1433-1438

Abstract

Background/Aims: Hepatocyte apoptosis is an important and invasive predictor of liver injury and fibrosis in non-alcoholic fatty liver disease (NAFLD). Increased gamma-glutamyltranspeptidase (GGT) level is frequently observed in NAFLD. Hepatocyte growth factor (HGF) Stimulates fibrogenesis and is correlated with GGT. The study aimed to determine whether GGT can distinguish NAFLD) patients at high risk.